Effects of Cardiovascular Drugs on Mortality in Severe Chronic Obstructive Pulmonary Disease
Magnus Ekström(Lund University), Kerstin Ström(Lund University), Anna Bornefalk‐Hermansson(Uppsala University Hospital)
American Journal of Respiratory and Critical Care Medicine
January 18, 2013
Cited by 158
Related Papers
Overuse of short-acting β<sub>2</sub>-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme
|European Respiratory Journal|2020|447
Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study
|BMJ|2014|298
Towards an expert consensus to delineate a clinical syndrome of chronic breathlessness
|European Respiratory Journal|2017|298
Home Oxygen Therapy for Adults with Chronic Lung Disease. An Official American Thoracic Society Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2020|298
Adaptation of the Charlson Comorbidity Index for Register-Based Research in Sweden
|Clinical Epidemiology|2021|267